Author:
Root James A.,Davey Dorren A.,Af Forselles Kerry J.
Reference22 articles.
1. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs;Abramovitz;Biochim. Biophys. Acta,2000
2. Severe cystitis associated with tiaprofenic acid;Ahmed;Br. Med. J.,1991
3. Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndrome;Chapple;J. Urol.,2014
4. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes;Coleman;Pharmocol. Rev.,1994
5. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain;Giblin;Bioorg. Med. Chem. Lett.,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献